ArticleFrontiers in oncology2013

Can pharmacological receptor tyrosine kinase inhibitors sensitize poor outcome breast tumors to immune-based therapies?

Josie Ursini-SiegelPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.